Rothschild Investment LLC Ab Cellera Biologics Inc. Transaction History
Rothschild Investment LLC
- $1.77 Trillion
- Q3 2025
A detailed history of Rothschild Investment LLC transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 15,815 shares of ABCL stock, worth $58,357. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,815Holding current value
$58,357% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ABCL
# of Institutions
168Shares Held
109MCall Options Held
1.26MPut Options Held
788K-
Baker Bros. Advisors LP New York, NY27.5MShares$102 Million1.13% of portfolio
-
Capital World Investors Los Angeles, CA13.4MShares$49.3 Million0.01% of portfolio
-
Baillie Gifford & CO10.4MShares$38.5 Million0.04% of portfolio
-
Two Sigma Investments, LP New York, NY5.18MShares$19.1 Million0.04% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny4.8MShares$17.7 Million0.05% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $1.05B
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...